Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
49.20    0.70 (1.44%)
Bid:
48.85
Ask:
49.55
Spread: 0.70 (1.433%)
Market Cap: £311.37m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

COVID-19 Update re: securitisation waiver granted

20 Apr 2020 07:00

RNS Number : 1169K
Marston's PLC
20 April 2020
Β 

20 April 2020

Β 

MARSTON'S PLC

("Marston's" or "the Group")

Β 

COVID-19 Update re: securitisation waiver granted

Β 

Marston's provides the following update in light of the COVID-19 virus.

We continue to take an extremely prudent approach in our management of the business during this period of unprecedented uncertainty, the timescale of which remains unclear pending further guidance from the UK Government as to how, and when, the current state of much reduced social activity can be relaxed and pubs allowed to re-open.

Β 

In addition to the actions which have been taken to reduce the Group's overall cost base, outlined in our previous update on 18 March, Marston's Issuer PLC has also taken the precautionary measure of securing a waiver of a breach that might arise under the 30 day suspension of business and operations provision under the terms of the Group's secured funding platform. The waiver has been granted until 29 May 2020 with an automatic extension to 15 June 2020 in certain circumstances.

Β 

The Group is also reviewing whether there is a need to consult with bondholders about further possible covenant waiversΒ under the secured funding platform in light of the impact of the UK Government's measures on the business.

Β 

Β 

Β 

ENQUIRIES:

Marston's PLC Tel: 01902 329516

Instinctif Partners

Ralph Findlay, Chief Executive Officer

Justine Warren Tel: 07785 555692

Andrew Andrea, Chief Financial and Corporate Development Officer

Matthew Smallwood Tel: 07831 379122

Β 

NOTES TO EDITORS

Β· Marston's is a leading pub operator and independent brewer.

Β· It has an estate of around 1,400 pubs situated nationally, comprising managed, franchised and leased pubs.

Β· It is the UK's leading brewer of premium cask and packaged ales, including Marston's Pedigree, Wainwright, Lancaster Bomber and Hobgoblin. The beer portfolio also includes Banks's, Jennings, Wychwood, Ringwood, Brakspear and Mansfield beers. Marston's has added Bombardier, Courage and McEwan's to its brand portfolio most recently, as well as a range of licensed brands including Young's, Founders and Estrella Damm.

Β· Marston's employs around 14,000 people.

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
UPDKKCBBKBKBOQD
Date   Source Headline
26th Jun 20231:08 pmRNSDirector/PDMR Shareholding
25th May 20238:16 amRNSDirector/PDMR Shareholding
24th May 20238:48 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 1 APRIL 2023
31st Mar 20237:00 amRNSAmendment and extension of debt facilities
22nd Mar 202310:19 amRNSHolding(s) in Company
24th Jan 20232:01 pmRNSResult of AGM
24th Jan 20237:00 amRNSTrading for the 16-week period to 21 January 2023
10th Jan 20233:07 pmRNSBlock listing Interim Review
6th Jan 20233:11 pmRNSHolding(s) in Company
3rd Jan 20239:42 amRNSHolding(s) in Company
21st Dec 20225:05 pmRNSConfirmation of Covenant Amendments
21st Dec 20222:34 pmRNSAnnual Financial Report
14th Dec 20229:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSPreliminary Results for 52 weeks ended 1 Oct 2022
5th Dec 202212:31 pmRNSConfirmation of Final Results announcement date
30th Nov 202210:46 amRNSHolding(s) in Company
28th Nov 202212:55 pmRNSChange to Final Results date and update on trading
28th Nov 20229:59 amRNSHolding(s) in Company
25th Nov 202212:04 pmRNSHolding(s) in Company
17th Nov 20229:14 amRNSHolding(s) in Company
17th Nov 20227:09 amRNSDirector Declaration re: New Directorship
10th Nov 202210:47 amRNSHolding(s) in Company
9th Nov 20228:15 amRNSHolding(s) in Company
3rd Nov 20224:25 pmRNSHolding(s) in Company
3rd Nov 20223:05 pmRNSHolding(s) in Company
11th Oct 20227:00 amRNSTrading update for the 52 weeks to 1 October 2022
6th Oct 20229:31 amRNSCorrection re Holding(s) in Company
5th Oct 202212:15 pmRNSHolding(s) in Company
12th Sep 20229:43 amRNSDirector/PDMR Shareholding
5th Sep 202212:27 pmRNSDirector/PDMR Shareholding
2nd Sep 202210:14 amRNSDirector/PDMR Shareholding
31st Aug 20222:51 pmRNSHolding(s) in Company
27th Jul 20227:00 amRNSTrading update for the 42 weeks to 23 July 2022
11th Jul 202212:03 pmRNSBlock listing Interim Review
7th Jul 20229:55 amRNSHolding(s) in Company
29th Jun 20228:45 amRNSDirector/PDMR Shareholding
13th Jun 20228:30 amRNSDirector/PDMR Shareholding
30th May 20222:14 pmRNSHolding(s) in Company
25th May 20228:54 amRNSHolding(s) in Company
20th May 202210:15 amRNSDirector/PDMR Shareholding
19th May 20227:00 amRNSInvestor Meet Company Presentation
18th May 20227:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 2 APRIL 2022
5th Apr 202212:39 pmRNSHolding(s) in Company
30th Mar 20228:28 amRNSDirector/PDMR Shareholding
28th Mar 20229:49 amRNSHolding(s) in Company
17th Mar 202210:18 amRNSHolding(s) in Company
8th Mar 202210:06 amRNSHolding(s) in Company
7th Mar 20227:00 amRNSDirectorate Change
3rd Mar 20229:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.